P0859 - Clinical study of VERU-111, an oral cytoskeletal disruptor in men with metastatic Castration Resistant Prostate Cancer (mCRPC) who failed an androgen receptor targeting agent
| Autor: | Getzenberg, R., Markowski, M.C., Tutrone, R., Eisenberger, M.A., Pieczonka, C., Rodriguez, D., Barnette, K.G., Steiner, M.S., Saltzstein, D.R., Antonarakis, E.S. |
|---|---|
| Zdroj: | In European Urology June 2021 79 Supplement 1:S1202-S1202 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect